Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsConstruction in ProgressCurrent AssetsCurrent Deferred Tax AssetsCurrent Deferred Tax AssetsCurrent TaxesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Other Non-Current Liabilities (2017 - 2026)

Dr Reddys Laboratories has reported Other Non-Current Liabilities over the past 10 years, most recently at $37.7 million for Q1 2026.

  • For Q1 2026, Other Non-Current Liabilities fell 1.26% year-over-year to $37.7 million; the TTM value through Mar 2026 reached $37.7 million, down 1.26%, while the annual FY2026 figure was $37.7 million, 3.43% down from the prior year.
  • Other Non-Current Liabilities for Q1 2026 was $37.7 million at Dr Reddys Laboratories, down from $38.1 million in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $47.8 million in Q1 2024 and troughed at $32.2 million in Q1 2022.
  • A 5-year average of $38.1 million and a median of $37.7 million in 2026 define the central range for Other Non-Current Liabilities.
  • Biggest five-year swings in Other Non-Current Liabilities: skyrocketed 37.95% in 2024 and later decreased 20.19% in 2025.
  • Year by year, Other Non-Current Liabilities stood at $32.2 million in 2022, then increased by 7.56% to $34.6 million in 2023, then surged by 37.95% to $47.8 million in 2024, then decreased by 20.19% to $38.1 million in 2025, then dropped by 1.26% to $37.7 million in 2026.
  • Business Quant data shows Other Non-Current Liabilities for RDY at $37.7 million in Q1 2026, $38.1 million in Q1 2025, and $47.8 million in Q1 2024.